Diabetes' Drugs Avandia and Actos

Joe Saunders

Attorney
(866) 735-1102 Ext 340

1 CommentPrint ArticleSubscribe

A panel of outside FDA advisers will be asked what types of studies should be conducted in order to evaluate the safety of diabetes' drugs Avandia and Actos, both of which have been linked to cardiac problems. Just last year, the FDA suggested the drugs should carry the highest possible warning labels.

``Questions have been raised as to whether long-term cardiovascular trials should be part of the approval process for pharmacological therapies developed for the treatment of diabetes,'' according to the FDA briefing document, prepared for the panel's meeting. "